Information Hub
Access guidance, webcasts and publications with commentaries using the ABS Information Hub. Search by classification or using keywords.
To view the webcasts from previous ABS Conferences, events and webinars you must be an ABS member and be logged in using your membership username and password.
Use this guidance key to help search the ABS Information Hub more effectively. Keywords are grouped under nine main themes that reflect key areas of clinical practice in breast care. By using these keywords to guide your search, you can quickly locate relevant guidelines, webcasts, publications and toolkits tailored to specific topics of interest.
Adjuvant & Neoadjuvant Treatment
- Adjuvant chemotherapy treatment guidelines
- Bisphosphonates
- Endocrine therapy
- Neoadjuvant therapy
- Radiotherapy
- Tumour profiling
Benign & Atypical Breast Disease
- Fibroadenoma management
- Gynaecomastia
- Management of nipple discharge
Breast & Oncoplastic Surgery
- Antibiotic Prophylaxis
- Axilla
- Biological & synthetic mesh assisted breast reconstruction
- Implant loss/ removal
- Lipomodelling
- Negative pressure wound dressings
- Oncoplastic breast reconstruction
- Prepectoral implant-based breast reconstruction
- Sentinel Lymph Node Biopsy
- Surgical margins
- Surgical site infections
- Surgical techniques
- Sutures
- Venous thromboembolism
- Wound drains
Breast Cancer Risk
- Contralateral mastectomy
- Management of high risk patients
- Risk reducing surgery
Breast Cancer Treatment
- Advanced breast cancer
- Early and locally advanced breast cancer
- Management of the older patient
- Management of the younger patient
- Pregnancy associated breast cancer
Cosmetic Surgery
- BIA ALCL
- Breast imaging before/ after aesthetic surgery
Post Treatment Surveillance & Care
- Follow up
- Hormone replacement therapy
- Lymphoedema
- Management of oestrogen deficiency symptoms
- Surveillance mammography
Screening & Diagnosis
- B3 lesions
- Imaging guidance
- QA guidelines
- Screening assessment
- Symptomatic diagnostic guidance
Service Guidance
- Breast cancer management quality standards
- Breast services standards
- Commissioning
- Consent
- COVID 19 service guidance
- Documentation
- MDT Meetings
- Outcomes in breast cancer
- Patient communication
- Paediatric breast patients
-
desktop_windows
The value of progesterone receptor expression in predicting PCR following NACT
Miss Emily King | ABS Conference 2023
15.05.2023 | Added: 15.05.2023
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT
desktop_windowsWebcast desktop_windows -
desktop_windows
Surgery after neo-adjuvant chemotherapy why are breast conservation rates not higher?
Dr Hiram S. Cody III | ABS Conference 2023
15.05.2023 | Added: 15.05.2023
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT
desktop_windowsWebcast desktop_windows -
list
Radiotherapy dose fractionation: fourth edition
This UK wide guidance, produced by the Clinical Oncology Group of the Royal College of Radiologists, updates the UK consensus statement on post operative radiotherapy for breast cancer from 2016
The Royal College of Radiologists
01.01.2023 | Added: 20.08.2025
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Radiotherapy
listGuideline list -
menu_book
MonarchE is an open-label, randomised, phase 3 trial which recruited high risk hormone receptor positive, HER2 receptor negative, node-positive breast cancer patients (n=5637). Patients were randomise...
Prof Stephen R D Johnston, MD et al | The Lancet Oncology
06.12.2022 | Added: 06.12.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Adjuvant treatment Endocrine therapy Trials
menu_bookPublication menu_book -
menu_book
This prospective multicentre cohort study aimed to determine surgical decision-making in the breast and axilla, as well as pathological complete response (pCR) rate in patients undergoing neoadjuvant ...
Hiba Fatayer et al | British Journal of Surgery
09.09.2022 | Added: 09.09.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT Early Breast Cancer Trials
menu_bookPublication menu_book -
desktop_windows
Introduction to the ABS, BSBR & UKBCG Guidance on Neoadjuvant Chemotherapy
ABS | Webinar
06.09.2022 | Added: 06.09.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT
desktop_windowsWebcast desktop_windows -
menu_book
This study evaluated histological pattern of residual tumour in patients who received neoadjuvant chemotherapy (NACT) in order to determine whether this affected oncological outcomes. The study cohort...
Alison Laws MD et al | Annals of Surgical Oncology
09.07.2022 | Added: 09.07.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT Recurrence
menu_bookPublication menu_book -
list
In 2022 NICE published an exceptional review to examine any impact on NICE's guideline on early and locally advanced breast cancer of published evidence on the indications for using adjuvant bisphosph...
NICE
01.07.2022 | Added: 20.08.2025
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Bisphosphonates
listGuideline list -
desktop_windows
Alexandra Zaborowski | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT Axilla
desktop_windowsWebcast desktop_windows -
desktop_windows
Systemic Therapy during pregnancy and in the postpartum
Anne Armstrong | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Systemic therapy Pregnancy Associated Breast Cancer/ PABC
desktop_windowsWebcast desktop_windows -
desktop_windows
Samantha Nimalesena | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Pregnancy Associated Breast Cancer/ PABC Radiotherapy
desktop_windowsWebcast desktop_windows -
desktop_windows
Iain MacPherson | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT Trials
desktop_windowsWebcast desktop_windows -
desktop_windows
Compliance with adjuvant endocrine therapy and management of side effects
Ann Partridge | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine Therapy
desktop_windowsWebcast desktop_windows -
desktop_windows
Supporting women with adherence to endocrine therapy
Linda Sharp & Eila Watson | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine Therapy
desktop_windowsWebcast desktop_windows -
desktop_windows
Peter Schmid | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Immunotherapy
desktop_windowsWebcast desktop_windows -
desktop_windows
Stuart McIntosh | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT
desktop_windowsWebcast desktop_windows -
desktop_windows
Oncology - Latest guidance (NACT)
Prof Carlo Palmieri | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT
desktop_windowsWebcast desktop_windows -
desktop_windows
Imaging - Latest guidance (NACT)
Sarah Vinnicombe | ABS Conference 2022
16.05.2022 | Added: 16.05.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT
desktop_windowsWebcast desktop_windows